All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
ARGX / argenx SE - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
KURA / Kura Oncology, Inc.
|
|
|
|
|
|
|
|
MRTX / Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
TNGX / Tango Therapeutics, Inc.
|
|
|
|
|
|
|
|
BMRN / BioMarin Pharmaceutical Inc.
|
|
|
|
|
|
|
|
BEAM / Beam Therapeutics Inc.
|
|
|
|
|
|
|
|
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
FLNT / Fluent, Inc.
|
|
|
|
|
|
|
|
NVTA / Invitae Corporation
|
|
|
|
|
|
|
|
US03217L1061 / Amryt Pharma PLC Sponsored ADR (United Kingdom)
|
|
|
|
|
|
|
|
NFH / New Frontier Health Corporation - Class A
|
|
|
|
|
|
|
|
NFH.WS / New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a
|
|
|
|
|
|
|
|
SLGC / Standard BioTools Inc.
|
|
|
|
|
|
|
|
DYNE / Dyntek Inc
|
|
|
|
|
|
|
|
SRRA / Sierra Oncology Inc
|
|
|
|
|
|
|
|
SRZN / Surrozen, Inc.
|
|
|
|
|
|
|
|
VINC / Vincerx Pharma, Inc.
|
|
|
|
|
|
|
|
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
PRLD / Prelude Therapeutics Incorporated
|
|
|
|
|
|
|
|
DICE / DICE Therapeutics Inc
|
|
|
|
|
|
|
|
TCRX / TScan Therapeutics, Inc.
|
|
|
|
|
|
|
|
AKRO / Akero Therapeutics, Inc.
|
|
|
|
|
|
|
|
DAWN / Day One Biopharmaceuticals, Inc.
|
|
|
|
|
|
|
|
LIFE / aTyr Pharma, Inc.
|
|
|
|
|
|
|
|
VIR / Vir Biotechnology, Inc.
|
|
|
|
|
|
|
|
SYBX / Synlogic, Inc.
|
|
|
|
|
|
|
|
EXAS / Exact Sciences Corporation
|
|
|
|
|
|
|
|
KRTX / Karuna Therapeutics, Inc.
|
|
|
|
|
|
|
|
RUBY / Rubius Therapeutics, Inc.
|
|
|
|
|
|
|
|
KALV / KalVista Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
BLUE / bluebird bio, Inc.
|
|
|
|
|
|
|
|
SGEN / Seagen Inc
|
|
|
|
|
|
|
|
TVTX / Travere Therapeutics, Inc.
|
|
|
|
|
|
|
|
HRMY / Harmony Biosciences Holdings, Inc.
|
|
|
|
|
|
|
|
EAR / Eargo, Inc.
|
|
|
|
|
|
|
|
INCY / Incyte Corporation
|
|
|
|
|
|
|
|
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
STSA / Satsuma Pharmaceuticals Inc
|
|
|
|
|
|
|
|
OTIC / Otonomy Inc
|
|
|
|
|
|
|
|
EXEL / Exelixis, Inc.
|
|
|
|
|
|
|
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
RANI / Rani Therapeutics Holdings, Inc.
|
|
|
|
|
|
|
|
ONC / BeOne Medicines AG - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
ILMN / Illumina, Inc.
|
|
|
|
|
|
|
|
RETA / Reata Pharmaceuticals Inc - Class A
|
|
|
|
|
|
|
|
BOLT / Bolt Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
PACB / Pacific Biosciences of California, Inc.
|
|
|
|
|
|
|
|
GRTX / Galera Therapeutics, Inc.
|
|
|
|
|
|
|
|
ALXO / ALX Oncology Holdings Inc.
|
|
|
|
|
|
|
|
ABCL / AbCellera Biologics Inc.
|
|
|
|
|
|
|
|
KOD / Kodiak Sciences Inc.
|
|
|
|
|
|
|
|
XENE / Xenon Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
EXAI / Exscientia plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
KYMR / Kymera Therapeutics, Inc.
|
|
|
|
|
|
|
|